 
        
        
        TAK-733是一种强效且选择性的 MEK 刺激位点抑制剂,对 MEK1 的 IC50 为 3.2 nM,对 Abl1、AKT3、c-RAF、CamK1、CDK2、c-Met 等无效。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | MEK ↓ ↑ | MEK1 ↓ ↑ | MEK1/2 ↓ ↑ | MEK2 ↓ ↑ | MEK5 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Honokiol | ✔ | 98% | |||||||||||||||||
| Mirdametinib | ++++ MEK, IC50: 0.33 nM | 99%+ | |||||||||||||||||
| Binimetinib | +++ MEK, IC50: 12 nM | 99%+ | |||||||||||||||||
| BI-847325 | ++ MEK1, IC50: 25 nM | +++ MEK2, IC50: 4 nM | 99%+ | ||||||||||||||||
| U0126-EtOH | + MEK1, IC50: 0.07 μM | ++ MEK2, IC50: 0.06 μM | 98% | ||||||||||||||||
| GDC-0623 | ++++ MEK1, IC50: 0.13 nM | 99%+ | |||||||||||||||||
| TAK-733 | ++++ MEK1, IC50: 3.2 nM | 99%+ | |||||||||||||||||
| Trametinib | ++++ MEK1, IC50: 0.92 nM | ++++ MEK2, IC50: 1.8 nM | 99%+ | ||||||||||||||||
| Selumetinib | +++ MEK1, IC50: 14 nM MEK1, Kd: 99 nM | + MEK2, Kd: 530 nM | 99%+ | ||||||||||||||||
| CI-1040 | ++ MEK1, IC50: 17 nM | ++ MEK2, IC50: 17 nM | 99%+ | ||||||||||||||||
| Myricetin | ✔ | 98% | |||||||||||||||||
| Refametinib | ++ MEK1, IC50: 19 nM | ++ MEK2, IC50: 47 nM | 99%+ | ||||||||||||||||
| Cobimetinib | +++ MEK1, IC50: 4.2 nM | 99%+ | |||||||||||||||||
| PD98059 | + MEK1, IC50: 2 μM | 99%+ | |||||||||||||||||
| SL327 | + MEK1, IC50: 0.18 μM | + MEK2, IC50: 0.22 μM | AP-1 | 98+% | |||||||||||||||
| PD318088 | ✔ | 99% | |||||||||||||||||
| AZD8330 | +++ MEK1/2, IC50: 7 nM | 99%+ | |||||||||||||||||
| Pimasertib | 98% | ||||||||||||||||||
| (E/Z)-BIX02189 | ++++ MEK5, IC50: 1.5 nM | 99%+ | |||||||||||||||||
| (E/Z)-BIX02188 | +++ MEK5, IC50: 4.3 nM | 99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc. | 
| Administration | Dosage | Frequency | Description | References | ||
| Athymic nude mice | PDTX models | Oral gavage | 10 mg/kg or 25 mg/kg | Once daily for a study duration | To evaluate dosing efficacy and antitumor activity. | Mol Cancer Ther. 2015 Feb;14(2):317-25 | 
| 细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 | 
| A375 cells | Cytotoxicity assay | 72 h | Cytotoxicity against human A375 cells after 72 hrs by MTS assay, EC50=3.1 nM | 21310613 | |
| COLO205 cells | Cytotoxicity assay | 72 h | Cytotoxicity against human COLO205 cells after 72 hrs by MTS assay, EC50=0.0021 μM | 21310613 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.98mL 0.40mL 0.20mL | 9.92mL 1.98mL 0.99mL | 19.83mL 3.97mL 1.98mL | |
| CAS号 | 1035555-63-5 | 
| 分子式 | C17H15F2IN4O4 | 
| 分子量 | 504.23 | 
| SMILES Code | O=C1C(C(NC2=CC=C(I)C=C2F)=C(F)C(N3C)=O)=C3N=CN1C[C@@H](O)CO | 
| MDL No. | MFCD24386349 | 
| 别名 | |
| 运输 | 蓝冰 | 
| InChI Key | RCLQNICOARASSR-SECBINFHSA-N | 
| Pubchem ID | 24963252 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C | 
| 溶解方案 | DMSO: 35 mg/mL(69.41 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1